T2W | 95% CI | T2W + DWI | 95% CI | |
---|---|---|---|---|
Sensitivity% | 86.9 | (0.65−0.96) | 96.1 | (0.78−0.99) |
Specificity% | 50 | (0.20−0.79) | 71.4 | (0.30−0.94) |
PPV% | 80 | (0.58−0.92) | 92.6 | (0.74−0.98) |
NPV% | 62.5 | (0.25−0.89) | 83.3 | (0.36−0.99) |
Accuracy% | 75.7 | (0.57−0.88) | 81.8 | (0.63−0.92) |
All | pCR | non-pCR | |
---|---|---|---|
59.6 ±11.5 | 58.5 ±11.2 | 59.9 ±11.8 | |
= number of individuals; CRT = chemoradiotherapy; pCR = pathologic complete response |
|||
Male | 18 | 5 | 13 |
Female | 15 | 2 | 13 |
= number of individuals; CRT = chemoradiotherapy; pCR = pathologic complete response |
|||
T2 | 3 | 1 | 2 |
T3 | 23 | 5 | 18 |
T4 | 7 | 1 | 6 |
= number of individuals; CRT = chemoradiotherapy; pCR = pathologic complete response |
5.1 (± 2.2) | 6.1 (± 1.3) | 4.8 (± 2.3) |
= number of individuals; CRT = chemoradiotherapy; pCR = pathologic complete response |
|||
Low anterior resection | 15 | 3 | 12 |
Abdominoperineal resection | 15 | 4 | 11 |
Pelvic exenteration | 3 | 0 | 3 |
= number of individuals; CRT = chemoradiotherapy; pCR = pathologic complete response |
|||
Well differentiated | 6 | 2 | 4 |
Moderately differentiated | 23 | 4 | 19 |
Poorly differentiated | 4 | 1 | 3 |